These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21527033)

  • 41. Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.
    Okado JB; Avaca-Crusca JS; Oliveira AL; Dabul ANG; Camargo ILBDC
    J Glob Antimicrob Resist; 2018 Sep; 14():209-216. PubMed ID: 29753135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current status of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus isolated from patients with skin and soft tissue infections in Japan.
    Nakaminami H; Ozawa K; Sasai N; Ikeda M; Nemoto O; Baba N; Matsuzaki Y; Sawamura D; Shimoe F; Inaba Y; Kobayashi Y; Kawasaki S; Ueki T; Funatsu S; Shirahama S; Noguchi N
    J Dermatol; 2020 Nov; 47(11):1280-1286. PubMed ID: 32696497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
    Hafer C; Lin Y; Kornblum J; Lowy FD; Uhlemann AC
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5845-51. PubMed ID: 22948864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
    Changchien CH; Chen SW; Chen YY; Chu C
    BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.
    Spagnolo AM; Orlando P; Panatto D; Amicizia D; Perdelli F; Cristina ML
    J Prev Med Hyg; 2014 Dec; 55(4):137-44. PubMed ID: 26137787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High frequency of Panton-Valentine leukocidin genes in invasive methicillin-susceptible Staphylococcus aureus strains and the relationship with methicillin-resistant Staphylococcus aureus in Córdoba, Argentina.
    Sola C; Saka HA; Vindel A; Bocco JL;
    Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):281-6. PubMed ID: 17345057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
    Mendes RE; Sader HS; Deshpande LM; Diep BA; Chambers HF; Jones RN
    J Clin Microbiol; 2010 Feb; 48(2):568-74. PubMed ID: 19940054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).
    Gould IM
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S17-21. PubMed ID: 23664580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Infectivity-resistotype-genotype clustering of methicillin-resistant Staphylococcus aureus strains in the Central Blacksea Region of Turkey].
    Kırca Yılmaz S; Acuner IC; Strommenger B; Bek Y; Witte W
    Mikrobiyol Bul; 2014 Jan; 48(1):14-27. PubMed ID: 24506712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of methicillin-resistant, vancomycin-intermediate Staphylococcus aureus among patients associated with group A Streptococcal pharyngitis infection in southern India.
    Gowrishankar S; Thenmozhi R; Balaji K; Pandian SK
    Infect Genet Evol; 2013 Mar; 14():383-9. PubMed ID: 23337611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric Staphylococcus aureus Isolate Genotypes and Infections from the Dawn of the Community-Associated Methicillin-Resistant S. aureus Epidemic Era in Chicago, 1994 to 1997.
    David MZ; Acree ME; Sieth JJ; Boxrud DJ; Dobbins G; Lynfield R; Boyle-Vavra S; Daum RS
    J Clin Microbiol; 2015 Aug; 53(8):2486-91. PubMed ID: 26019202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72.
    Baek JY; Chung DR; Ko KS; Kim SH; Yang SJ; Kang CI; Peck KR; Song JH
    J Antimicrob Chemother; 2017 Sep; 72(9):2454-2460. PubMed ID: 28595277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A rapid screening method for Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus belonging to multilocus sequence type 30 and its related clone using a combination of multiplex PCR and pulsed-field gel electrophoresis.
    Reva I; Higuchi W; Takano T; Singur O; Ozaki K; Isobe H; Yabe S; Saito K; Baranovich T; Enany S; Otsuka T; Potapov V; Nishiyama A; Yamamoto T
    J Infect Chemother; 2009 Apr; 15(2):75-83. PubMed ID: 19396516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
    Hsueh PR; Lee SY; Perng CL; Chang TY; Lu JJ
    Int J Antimicrob Agents; 2010 Oct; 36(4):307-12. PubMed ID: 20685086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus in Spain: 2004-12.
    Vindel A; Trincado P; Cuevas O; Ballesteros C; Bouza E; Cercenado E
    J Antimicrob Chemother; 2014 Nov; 69(11):2913-9. PubMed ID: 24990868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
    Lin SY; Chen TC; Chen FJ; Chen YH; Lin YI; Siu LK; Lu PL
    J Microbiol Immunol Infect; 2012 Dec; 45(6):435-41. PubMed ID: 22749725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
    Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Abdelhady W; Bayer AS; Seidl K; Nast CC; Kiedrowski MR; Horswill AR; Yeaman MR; Xiong YQ
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1447-54. PubMed ID: 23295925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection and genetic characterization of PVL-positive ST8-MRSA-IVa and exfoliative toxin D-positive European CA-MRSA-Like ST1931 (CC80) MRSA-IVa strains in Bangladesh.
    Paul SK; Ghosh S; Kawaguchiya M; Urushibara N; Hossain MA; Ahmed S; Mahmud C; Jilani MS; Haq JA; Ahmed AA; Kobayashi N
    Microb Drug Resist; 2014 Aug; 20(4):325-36. PubMed ID: 24552553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.